Trade name: Tabex
Composition: One filmtablet contains 1.5 mg alkaloid.
Other ingredients: Calcium dihydrogenphosphate, Lactose, Wheat starch, Microcrystalline cellulose, Talc, Magnesium stearate.
Pharmaco-therapeutic group: Vegetotropic agent - N- cholinomimetic (gangliostimulant).
Contraindications: Tabex is contraindicated in arterial hypertension and advanced atherosclerosis.
Warning:Tabex show that the product is effective and well tolerated. The adverse effects are insignificant in case of adequate treatment according to the schedule and do not necessitate reduction of the dose and shortening the duration of the treatment.
Pregnancy and lactation: The intraovular application of the substance to hen embryos induced no embriotoxic and teratogenic effect within the limits of the single therapeutic doses. On the base of the experimental data obtained, Tabex is recommended not to be taken by pregnant women, due to the potential risk of embryotoxic action in case of uncontrolled administration. The product should not be administered during breast feeding.
Effect of the product on drivers and machine operators: Tabex is considered safe and induces no changes in the physchophysical status, driving ability and machine operation.
Interactions: No data is available on undesired interactions between Tabex and other pharmaceuticals.
Administration and dosage: Tabex is administered perorally according to the following schedule:
After the end of the therapeutic course, in order to have good results, the patient should give evidence of strong will.
Undesired adverse effects: Tabex has a good tolerance and grave adverse effects were not observed. The following adverse effects are rather often observed at the beginning of Tabex treatment: changes in both taste and appetite, dryness in the mouth, headache, irritability, nausea, constipation, tachycardia, light elevation of the arterial pressure. The majority of the adverse effects can abate in the course of the treatment.
Supplied: The filmtablets Tabex are packed in PVC/aluminum foil blister strips. Each blister strip contains 20 filmtablets. Five blister strips are packed in a cardboard box together with package insert.
Storage: In original packages, in dry, and light-protected premises at temperature of 15° -25° C (60° - 75° F)
Expiry term: Two year from manufacture date
How dispensed: No physician prescription required
Name and address of manufacturer: Sopharma AD, 16 Iliensko Chossee St. Sofia, Bulgaria 1220.
Copyright © 2016-2018 BPG Ltd/Biogenic Stimulants, Inc. All rights reserved.